Does high-dose erythropoietin decrease the risk of death or severe neurodevelopmental impairment in preterm infants?
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Perinatology"
DOI: 10.1038/s41372-021-00931-z
Abstract: Subjects randomized to the intervention arm received highdose EPO (1000 units/kg) intravenous within 24 h of birth and every 48 h for a total of 6 doses, followed by EPO 400 units/kg subcutaneous three times… read more here.
Keywords: decrease risk; death severe; dose erythropoietin; high dose ... See more keywords
GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS DO NOT DECREASE THE RISK FOR CORONARY REVASCULARIZATION IN PATIENTS WITH TYPE 2 DIABETES: A META-ANALYSIS OF CARDIOVASCULAR OUTCOME TRIALS
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Hypertension"
DOI: 10.1097/01.hjh.0000837028.88430.4f
Abstract: Objective: Cardiovascular disease (CVD) is common among subjects with type 2 diabetes mellitus (T2DM), while it represents the main cause of death, accounting for half of deaths in this population. Prevalence of coronary artery disease… read more here.
Keywords: outcome; risk; coronary revascularization; decrease risk ... See more keywords
Melatonin may decrease risk for and aid treatment of COVID-19 and other RNA viral infections
Sign Up to like & getrecommendations! Published in 2021 at "Open Heart"
DOI: 10.1136/openhrt-2020-001568
Abstract: A recent retrospective study has provided evidence that COVID-19 infection may be notably less common in those using supplemental melatonin. It is suggested that this phenomenon may reflect the fact that, via induction of silent… read more here.
Keywords: decrease risk; treatment; covid; may decrease ... See more keywords